DXSE:XETRA:XETRA-Xtrackers - Stoxx Europe 600 Health Care Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 233.6

Change

-2.75 (-1.16)%

Market Cap

USD 0.14B

Volume

371.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-24 )

ETFs Containing DXSE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.48% 85% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.48% 85% B 81% B-
Trailing 12 Months  
Capital Gain 12.77% 55% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.77% 54% F 56% F
Trailing 5 Years  
Capital Gain 70.26% 79% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 70.26% 79% B- 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 8.56% 70% C- 68% D+
Dividend Return 8.56% 69% C- 66% D+
Total Return N/A 15% F 31% F
Risk Return Profile  
Volatility (Standard Deviation) 8.34% 67% D+ 74% C
Risk Adjusted Return 102.63% 99% N/A 99% N/A
Market Capitalization 0.14B 42% F 38% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.